In this quarterly update, I’m sharing the latest fibromyalgia research from ClinicalTrials.gov. There are several treatment-related studies including those for psychedelics, reconsolidation therapy with propranolol, acupuncture, pain education smartphone apps, sound therapy and more!
Let me know in the comments section below if you’re excited about any of these trials. I’m particularly interested in your opinions on the studies using psilocybin (psychedelic mushrooms) for fibro.
TRYP Therapeutics will conduct a small study involving 20 patients to test the safety of synthetic psilocybin therapy for fibromyalgia.
(Read more: Can psychedelics be used to treat fibromyalgia?)
(Read more: Psychedelics meet mainstream medicine)
The University of Alabama at Birmingham will study the efficacy of a psilocybin-facilitated treatment for fibromyalgia.
Researchers from Université de Sherbrooke in Canada will study the feasibility/acceptability of combining neuroscience education and reconsolidation therapy with propranolol as a treatment for fibromyalgia and chronic low back pain.
(Read more: What is reconsolidation therapy? This article focuses on PTSD, but the Canadian study linked above will follow a similar protocol for fibromyalgia.)
About 80 fibromyalgia patients will be assessed for their ability to dual task (i.e. perform two tasks simultaneously) during this study out of Izmir Katip Celebi University in Turkey.
I don’t usually go into great detail on these summaries since people can read the actual listing on ClinicalTrials.gov, but I had to include the task that my fellow fibro warriors will need to complete as part of the study:
“Participants are required to get up from the chair without assistance from their arms, walk 3 meters as fast as possible without running, turn their backs, walk back to the chair, and sit without assistance from their arms. The dual-task condition is performed by counting aloud backwards by twos, starting with a random number greater than 100 while performing the tests,” as summarized on ClinicalTrials.gov.
Am I the only one who felt anxious as soon as they finished reading that paragraph? There is NO WAY I could complete that task correctly!
Researchers from Guang’anmen Hospital of China Academy of Chinese Medical Sciences, China, will study the effectiveness of warm acupuncture among 38 fibromyalgia patients who are sensitive to the cold.
Around 300 fibromyalgia patients will evaluate the safety and efficacy of two digital therapy smartphone apps for Swing Therapeutics, a company that develops evidence-backed treatments for people with chronic conditions. One group of participants will use an app dedicated to Digital Acceptance and Commitment Therapy while the other will use an app to track and monitor their symptoms and functionality.
(Read more: What is Acceptance and Commitment Therapy?)
Colombian and Mexican researchers will test the effectiveness of a neuroscience education program focused on pain among 62 fibromyalgia patients.
Researchers from Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer, France, will “compare the effects of relaxation sessions with sound therapy delivered by tuning forks to a control group who will benefit from relaxation sessions without tuning fork activation” among 40 women with fibromyalgia, according to ClinicalTrials.gov.
About 80 fibromyalgia patients will test if eating tzabar fruit twice a day will reduce fatigue, pain and depression and improve quality of life during this study at Soroka University Medical Center, Israel.
(Read more: What is tzabar (aka prickly pear)?)
Now it’s your turn: Are you excited about any of these studies? What do you think of researchers studying psilocybin as a possible fibromyalgia treatment? Share your feedback in the comments section below!